"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
The SIQ for this article will be revealed
nasal obstruction surgery, radiotherapy, endoscopic surgery, chondrosarcoma, nasal septum
Azliana Aziz , Mohamed A. Malik Mohamed, Mohammad Habibullah Khan
Cite this article as: Aziz A, Mohamed M, Khan M (July 31, 2022) A Huge Chondrosarcoma of the Nasal Septum. Cureus 14(7): e27532. doi:10.7759/cureus.27532
Chondrosarcoma of the nasal septum is a rare malignancy. Its early diagnosis is difficult because of its non-specific sinonasal complaints. We report a case report of a 72-year-old woman who presented with progressive nasal obstruction and anosmia. Nasal endoscopy showed a nasal mass obstructing both nasal cavities, which was not separable from the nasal septum. Endoscopic biopsy confirmed chondrosarcoma. The tumour was operated on with complete margins by an endoscopic approach. The clinical presentation of the disease, diagnosis and treatment of this case, and a review of the literature are discussed.
Sinonasal chondrosarcoma is a rare tumour that represents approximately 5%-10% of malignant primary bone tumours that occur in the head and neck region [1]. The nasal septum is a rare site of origin for sinonasal chondrosarcoma and accounts for about 0.1% of the sinonasal region [2]. Chondrosarcoma is a malignant tumour with tendencies to arise from pure hyaline cartilage differentiation and may occur from chondrocytes, embryonal rests or mesenchymal cells that undergo multidirectional differentiation to form either cartilaginous or osseous [3] elements. It can arise from either bone or soft tissue [4]. The site of predilection for the head and neck chondrosarcoma includes ethmoid sinus, maxilla, nasal septum, hard palate, nasopharynx, and alar cartilage [5]. They rarely extend into the cranial or intracranial areas unless there is a recurrence [6] of the disease.
A very healthy and fit, 72-year-old lady was referred to an Otorhinolaryngology outpatient clinic with complaints of a slowly progressive history of nasal obstruction and anosmia for a few weeks. There was no history of vision loss, diplopia, proptosis, facial pain, facial asymmetry, weight loss or epistaxis. Intra-oral and ear examinations were normal.
The nasoendoscopy examination revealed a large central nasal mass occupying the nasal cavity. Both computed tomography (CT) and magnetic resonance imaging (MRI) was performed to fully evaluate the extension of the disease as well as the bone and soft-tissue characteristics of the lesion. CT scan of the sinuses showed a well-circumscribed sinonasal mass in the nasopharynx with the epicentre at the posterior nasal septum and expanding laterally that causing bowing of the medial nasal walls (Figure 1), eroding the sphenoid and clivus and exposing the right internal carotid artery (ICA) (Figure 2).
The MRI showed a detailed definition of the nature, extent and size of the mass. It showed an eroded and deformed nasal septum with the lesion abutting sphenoid cavernous sinuses (Figures 3, 4) posteriorly. There was also a mild narrowing of the superior orbital fissure bilaterally, abutting the optic nerves bilaterally without definite involvement. Figures 5, 6 demonstrated the sagittal view of the lesion in the CT and MRI scan. There was no neck adenopathy or any distant metastasis noted.
Endoscopic biopsies were performed and the histopathology examination confirmed grade 2 chondrosarcoma. This case was discussed by our multidisciplinary team, the decision was taken to remove the tumour by an endoscopic approach under general anaesthesia. The patient underwent endoscopic endonasal transsphenoidal surgery, a combined case with a neurosurgical team.
We used a Stealth station (Medtronic ENT Neuronavigation system). Intraoperatively, middle turbinates and lamina papyracea were identified and preserved. The whole of the posterior septum from the hard palate to the skull base was removed. Anterior skull base was drilled with minor cerebral spinal fluid (CSF) leak identified and sealed with factor Xa-like protein (Haemopatch) and DuraSeal. Sphenoid and clivus bone was drilled and right ICA was identified. There was no extension into the cavernous sinus was noted and the whole tumour was resected via an endoscopic approach.
Post-operatively, the case was discussed in a multi-disciplinary team meeting for postoperative radiotherapy. The patient currently opted for endoscopic and radiologic surveillance for her follow-up. Repeat MRI images after four months of endoscopic resection of the tumour were carried out and demonstrated completed resection of the chondrosarcoma (Figures 7, 8).
The patient underwent repeat biopsies and histological examination showed no disease recurrence. The endoscopic image during the time of biopsy after a few months of initial resection also revealed good healing after the operation (Figure 9).
R= Right inferior turbinate, L= Left inferior turbinate, F= Nasal floor, P= Palatine bone/hard palate, N= Nasopharynx
Chondrosarcoma is a non-epithelial malignant tumour, which is a slow-growing tumour that usually involves the pelvis, ribs, long bones of the extremities, scapula, and the sternum. It affects men and age groups between 60 and 70 years old. Chondrosarcoma can be associated with conditions such as multiple hereditary exostoses, Ollier disease, Maffucci syndrome [7], earlier usage of intravenous thorium dioxide contrast, Paget’s disease of bone, chondromyxoid fibroma and previous history of radiation [8].
The histology criteria are depending on the presence of many cells with hyperchromatic nuclei, two or more chondrocytes within a lacuna and giant cartilage cells with large single or multiple nuclei with clumps of chromatin and mitotic activity [5]. Chondrosarcoma is classified by the WHO according to the degree of cellularity, nuclear size, atypia and mitotic activity as grade 1 is well differentiated (low cellularity) with abundant hyaline cartilage matrix [9], which is commonly seen in the skull base at about 90%. Grade 1 chondrosarcoma mostly affects elderly patients aged between 60 and 70 years old and rarely metastasis. Grade 2 is moderately differentiated (medium). In contrast, grade 3 chondrosarcoma is poorly differentiated (highly cellular) with a mucomyxoid matrix and mitoses [9]. Grade 3 is seen in the younger age group (between 20 and 40 years old) and has a higher rate of recurrence in about 70% of patients [10].
The 5-year survival rate of chondrosarcoma is about 70%-80%, with a good prognosis [11]. However, it is known to slow progression and can cause multiple metastases, which are usually seen in patients who have undergone multiple operations over a period. The prognosis of nasal septum chondrosarcoma depends on the location and size of the tumour and the degree of differentiation. The rates of lymph node and distant metastasis are low about 5.6%-6.7% [12].
Complete excision of the primary site with adequate surgical margin is important for a successful outcome as chondrosarcoma is considered a radio-resistant tumour. As highlighted in this case, the use of a navigation system in an expert hand, as part of the surgical adjunct will enable complete resection of the tumour endoscopically. It also spares the open surgical approach and avoids associated complications to open surgery.
According to Lee et al., postoperative radiotherapy may have some role in the treatment of chondrosarcoma as two of the cases reported with a positive margin were successfully treated with postoperative radiotherapy [11]. Adjuvant chemotherapy also plays an extremely limited role and is reserved for residual or recurrent disease and palliation [13]. Postoperative follow-up for tumour surveillance is mandatory as it allows early recognition of residual or recurrence of disease which mandates repeat biopsy and imaging for further management of the disease.
Chondrosarcoma of the nasal septum is a rarely made diagnosis. Prompt diagnosis, surgical treatment and multi-disciplinary team involvement and discussion are paramount. Complete excision of the primary site with adequate margin can be curative. Long-term follow-up with endoscopic and radiological assessment is important due to the slow progression of the disease and the high rate of recurrence in the higher grade of chondrosarcoma.
Otorhinolaryngology, Head and Neck Surgery (ORL-HNS), Universiti Sains Malaysia School of Medical Sciences, Kota Bharu, MYS
Otorhinolaryngology, South Infirmary-Victoria University Hospital, Cork, IRL
Otorhinolaryngology, South Infirmary-Victoria University Hospital, Cork, IRL
Otorhinolaryngology, South Infirmary-Victoria University Hospital, Cork, IRL
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Aziz A, Mohamed M, Khan M (July 31, 2022) A Huge Chondrosarcoma of the Nasal Septum. Cureus 14(7): e27532. doi:10.7759/cureus.27532
Peer review began: June 28, 2022 Peer review concluded: July 23, 2022 Published: July 31, 2022
© Copyright 2022 Aziz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
R= Right inferior turbinate, L= Left inferior turbinate, F= Nasal floor, P= Palatine bone/hard palate, N= Nasopharynx
Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.
This link will take you to a third party website that is not affiliated with Cureus, Inc. Please note that Cureus is not responsible for any content or activities contained within our partner or affiliate websites.
Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. SIQ™ assesses article importance and quality by embracing the collective intelligence of the Cureus community-at-large. All registered users are invited to contribute to the SIQ™ of any published article. (Authors cannot rate their own articles.)
High ratings should be reserved for work that is truly groundbreaking in its respective field. Anything above 5 should be considered above average. While all registered Cureus users can rate any published article, the opinion of domain experts is weighted appreciably more than that of non-specialists. An article’s SIQ™ will appear alongside the article after being rated twice and is recalculated with each additional rating.
Visit our SIQ™ page to find out more.
Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. SIQ™ assesses article importance and quality by embracing the collective intelligence of the Cureus community-at-large. All registered users are invited to contribute to the SIQ™ of any published article. (Authors cannot rate their own articles.)
Already have an account? Sign in.
Please note that by doing so you agree to be added to our monthly email newsletter distribution list.
By joining Cureus, you agree to our Privacy Policy and Terms of Use.